You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (32)

Journals (0)

1-10 of 32 results for new anti-HER2 therapies

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

Open access

Review article

First published 2019

HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

Sonia Pernas, Sara M. Tolaney

Therapeutic Advances in Medical Oncology

Select article: Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies

Free access

Review article

First published 2016-11

Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies

Laurence Lousberg, Joëlle Collignon, Guy Jerusalem

Therapeutic Advances in Medical Oncology

Select article: Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer

Open access

Review article

First published 2019

Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer

Emilia Montagna, Marco Colleoni

Therapeutic Advances in Medical Oncology

Select article: Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients?

Open access

Review article

First published 2013

Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients?

Walter P. Carney, Dirk Bernhardt, Bharat Jasani

Biomarkers in Cancer

Select article: Endocrine therapy plus HER2-targeted therapy,another favorable option for HR+/HER2+ advanced breast cancer patients

Open access

Review article

First published 2024

Endocrine therapy plus HER2-targeted therapy,another favorable option for HR+/HER2+ advanced breast cancer patients

Yuehua Liang, Xiaoran Liu, Zehui Yun [...]

Therapeutic Advances in Medical Oncology

Select article: Expression of erbB Receptors and their Ligands in Breast Cancer: Implications to Biological Behavior and Therapeutic Response

Free access

Research article

First published 2000-6-1

Expression of erbB Receptors and their Ligands in Breast Cancer: Implications to Biological Behavior and Therapeutic Response

Sarah S. Bacus, Andrei V. Gudkov, Francisco J. Esteva [...]

Breast Disease

Select article: Neoadjuvant therapy of early stage human epidermal growth factor receptor 2 positive breast cancer: latest evidence and clinical implications

Free access

Review article

First published 2014-9

Neoadjuvant therapy of early stage human epidermal growth factor receptor 2 positive breast cancer: latest evidence and clinical implications

Sonia Pernas Simon

Therapeutic Advances in Medical Oncology

Select article: Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Open access

Review article

First published 2022-04

Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Jindong Xie, Yutian Zou, Ting Gao [...]

Cancer Control

Select article: Multicriteria decision analysis for HER2-positive non-metastatic breast cancer

Retricted access

Research article

First published 2026

Multicriteria decision analysis for HER2-positive non-metastatic breast cancer

Clarissa Ribeiro Duarte Lisboa, Maria Del Pilar Estevez-Diz, Alessandro Gonçalves Campolina

Journal of Oncology Pharmacy Practice

Select article: Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options

Free access

Review article

First published 2015-11

Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options

Hanfang Jiang, Hope S. Rugo

Therapeutic Advances in Medical Oncology

1
2
3
4
10 / page

Article type

Publication date

Subjects

Access